🇺🇸 FDA
Patent

US 8257699

Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases

granted A61KA61K2039/505A61K38/47

Quick answer

US patent 8257699 (Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases) held by HALOZYME, INC. expires Mon Aug 30 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
HALOZYME, INC.
Grant date
Tue Sep 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 30 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K2039/505, A61K38/47, A61K39/395, A61K39/3955